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Abstract
In recent years, there has been growing concern about the occurrence of metabolic syndrome (MetS) at an early
age and its effects on bone mass in adolescents. Adolescence is considered a critical period for bone mass gain.
Impaired bone acquisition during this phase can lead to “suboptimal” peak bone mass and increase the risk of
osteopenia/osteoporosis and fractures in old age. The objective of this review was to perform a critical analysis
of articles that specifically focus on this age group, evaluating the influence of MetS and its components on
bone mineral density in adolescents. A possible relationship between this syndrome and bone mass has been
demonstrated, but the number of studies addressing this topic in adolescents is small. Despite the scarcity of
evidence, the results of those studies show that Metabolic Syndrome is negatively correlated with bone mass
and also that some components of MetS are negatively correlated with bone mineral density in adolescents.
However, the associations between MetS and bone mass development need to be further explored in the age
group corresponding to adolescence. Further good-quality studies are necessary to complement the understanding
of this relationship.
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Background
Metabolic syndrome (MetS) is a clinical condition charac-
terized by a combination of abdominal obesity, altered glu-
cose metabolism, dyslipidemia, and arterial hypertension.
This combination of metabolic alterations predisposes
affected individuals to the development of cardiovascular
diseases and type 2 diabetes mellitus [1, 2]. In addition to
the cardiovascular problems extensively documented in
the scientific literature, previous studies have shown a pos-
sible relationship between MetS and bone mass, however
the results are still inconsistent [3–7].
In adults, studies have shown a negative correlation be-
tween MetS and bone mineral density (BMD) [3, 6, 8, 9].
These findings have been questioned in a recent systematic
review with meta-analysis, suggesting that BMD at differ-
ent sites does not differ between adult men and women
with and without MetS [10]. However, the authors sug-
gested caution in the interpretation of the results and indi-
cated the need for prospective studies [10]. Among
Caucasian Dutch adults, an association with femoral BMD
was observed in older women with MetS, even after adjust-
ment for confounding parameters such as body mass index
(BMI), age and lifestyle, while no such association was
found in older men. Analysis of the cohort showed a lower
odds ratio of osteoporosis and fractures in both genders
[11]. Unfortunately, that study only evaluated the femoral
region [11]. However, the authors emphasized that the
presence of MetS could increase fractures of the humerus
and ankle. Another hypothesis to explain the diversity of
the results of already published studies is the fact that the
presence of MetS associated with a reduction in BMD was
demonstrated for other ethnic groups and younger individ-
uals, and therefore depends on the population studied.
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With respect to adolescence, literature reviews on the rela-
tionship between MetS and BMD are sparse [4, 5, 7].
Adolescence is considered a critical period for bone
mass gain. The greatest gains in bone occur during this
phase when peak bone mass is reached [12]. Impaired
bone growth during this period can lead to “suboptimal”
peak bone mass and increase the risk of developing osteo-
penia/osteoporosis and fractures in old age [13, 14].
In view of these considerations, the objective of the
present study was to review the possible effects of MetS
and its components on BMD in adolescents.
Search strategy and article selection
A literature review was performed. The following elec-
tronic databases were searched for articles published over
a period of 10 years (January 2004 to June 2015), without
language restrictions: Scientific Electronic Library
Online (SciELO), Latin American and Caribbean Health
(LILACS), Medline, PubMed, Scopus, and Cochrane
Library.
The following MeSH terms were used alone or in com-
bination: “metabolic syndrome or metabolic syndrome X
or plurimetabolic syndrome or MetS or cardiometabolic
risk factors or cardiovascular disease or cardiovascular dis-
ease risk factors” or “abdominal obesity or waist circum-
ference” or “hypertriglyceridemia” or “HDL cholesterol” or
“diastolic blood pressure or systolic blood pressure” or
“fasting glucose” and “bone densities or bone mineral
density or bone mineral densities or density, bone min-
eral or bone mineral content or bone mineral contents
or bone density or physiological calcification or bone
mineralization”, and “adolescents or adolescence or teens
or teen or teenagers or teenager or youth or youths”.
Human studies on the association between MetS and
bone mass, regardless of sample size, were included if they
met the following criteria: overweight adolescents with
cardiometabolic risk factors (waist circumference, HDL
cholesterol, triglycerides, diastolic blood pressure, systolic
blood pressure, fasting glucose) and aged ≥ 10 years. We
considered cohort studies as well as cross-sectional stud-
ies. The latter is an anticipation of not finding many
prospective studies with a control group. BMD or bone
mineral content (BMC) or bone area was measured by
dual-energy X-ray absorptiometry (DXA). Comments, let-
ters, and articles containing only the abstracts without the
full text were excluded.
At the time of the initial database search twenty stud-
ies were identified and selected to be included in the
review based on the predefined inclusion criteria. After
reading the titles and abstracts, 14 studies that did not
meet the inclusion criteria for the review were excluded:
age of the study population < 10 years, absence of groups
of adolescents with excess weight, lack of comparison be-
tween eutrophic and overweight adolescents, absence of
cardiometabolic risk factors, use of other methods for
the evaluation of BMD, BMC or bone area, and pres-
ence of other diseases or syndromes associated with
MetS.
Metabolic syndrome and bone mass
Literature reviews on the relationship between a diagno-
sis of MetS and risk factors during puberty and BMD in
adolescents are sparse [4, 5, 7, 14–16]. Table 1 shows the
results of some studies on the topic found in the scientific
literature according to date of publication and interest in
investigating the risk factors of metabolic syndrome, with
bone mass evaluated through densitometry in adolescents.
Afghani et al. [15] studied a cohort of overweight
Latin American children and adolescents with a family
history of type 2 diabetes mellitus. The authors ob-
served that total body BMC was negatively correlated
with the presence of markers of insulin resistance; how-
ever, they did not evaluate the effects of other MetS
components on bone mass. Similar findings have been
reported by Pollock et al. [16] who evaluated total body
BMC and BMD in overweight prepubertal children with
and without pre-diabetes. These authors observed a sig-
nificant reduction in both BMC and BMD in the group
with pre-diabetes and hyperinsulinemia. In a subse-
quent study, Pollock et al. [4] compared bone mass be-
tween overweight adolescents (14 to 18 years) with and
without cardiometabolic risk factors. In that study,
BMC was reduced by 5.4% in adolescents that had at
least one component of MetS compared to those with-
out any risk factor, and by 6.3% when two or more risk
factors were present. The authors found no correlation
between elevated triglyceride levels and BMC; however,
increased waist circumference, increased visceral fat tis-
sue, fasting insulin and homeostasis model assessment
of insulin resistance (HOMA-IR) showed significant
negative correlations with total body BMC. In contrast,
HDL-cholesterol and total energy intake were positively
associated with BMC. In a comment on the study of
Pollock et al. [4], Kalkwarf [17] emphasized that these
findings were only detected after adjusting total body
BMC for fat-free soft tissue mass, assuming that, if the
crude BMC values were not adjusted, they would mis-
leadingly indicate that bone mass increases with in-
creasing body weight, a situation previously reported in
the literature.
The results published by Mosca et al. [18] corroborate
these findings by demonstrating a negative correlation
between BMD of overweight, obese or extremely obese
adolescents and the percentage of fat mass determined by
DXA. The authors concluded that the higher the body fat
percentage of adolescents, the lower the BMD and BMC
[18]. Complementing these considerations, it should be
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emphasized that the prevalence of MetS is higher among
extremely obese adolescents [19].
Lawlor et al. [5] conducted a cross-sectional study in-
volving a sample of 2305 adolescents in an attempt to
demonstrate associations of markers related to insulin
resistance (fasting glucose and insulin), triglycerides and
HDL-cholesterol with BMD. Controlling for the covari-
ates age, height and pubertal stage in multivariate ana-
lysis, the authors found no significant correlation
between fasting glucose and BMD. Triglycerides were
positively correlated with BMD, BMC and bone area in
boys. HDL-cholesterol showed an inverse correlation
with BMD, BMC and bone area in both genders. After
adjusting for fat mass, fasting insulin in boys was in-
versely correlated with bone mass. According to these
authors, this finding after adjustment for fat mass should
be treated with caution and further prospective studies
are needed to replicate and explore the results.
A recent study published by Brazilian researchers found
a reduction in BMD at different sites in overweight ado-
lescents with MetS when compared to adolescents in the
same nutritional condition, but without MetS. Further-
more, adolescents with two or more risk factors for MetS
exhibited a significant reduction in bone mass compared
to those with no or only one risk factor. Among the MetS
components, waist circumference was the determinant
factor for BMD reduction [7].
It can be observed that the majority of the studies found
were transversal with evaluation of bone densitometry
through DXA. In relation to bone histomorphometry,
quantitative histological evaluation of calcified bone bi-
opsy performed to obtain information on remodeling and
bone structure, a recent experimental study was detected,
being constructed to evaluate, among other parameters,
the bone histomorphometry of the tibia and vertebra of
experimental animals, in the growth phase and mature,
who received a diet rich in saturated fat and sucrose
(HFS), against animals considered controls, who received
diet chow. The authors concluded that the animals
submitted to HFS developed a phenotype characterized
by excess visceral fat, which presented through in-
creased abdominal circumference and body weight,
non-alcoholic hepatic steatosis, and a 334% increase in
basal insulinemia in those in the growth phase and
86% in mature rats, indicating insulin resistance, alter-
ations that resembled metabolic syndrome comorbidi-
ties. The mature rats maintained in this scheme also
developed pressure alterations and a reduction in HDL
cholesterol. In addition, after 27 weeks of follow-up,
the animals presented a reduction in active osteocalcin
(OC). These animals also presented reduced calcemia
and increased phosphataemia, in addition to a reduc-
tion in the bone surface, thickness of the osteoid, with
more important alterations in the vertebral bones than
in the tibia, since these suffered the impact of the load.
The authors proposed that metabolic syndrome caused
by dietary HFS intake increased the porosity of the
cortex of the tibia [20].
Table 1 Studies evaluating the association of metabolic syndrome or a separately altered component with BMC, BMD in
adolescents
Study Country Sample Design Outcome
measures
Results - association between MetS
or risk factors and bone mass
Afghani et al. [15] California/USA 184 overweight
(8 to 13 years)
Cross-sectional BMC using DXA Insulin resistance↓ body BMC
Pollock et al. [16] Georgia/USA 140 overweight
(7 to 11 years)
Cross-sectional BMC and BMD
using DXA
Pre-diabetes ↓BMC and BMD
Hyperinsulinemia ↓BMC and BMD
Pollock et al. [4] Georgia/USA 143 overweight adolescents
with cardiometabolic risk
factors (14 to 18 years)
Cross-sectional BMC using DXA ↑HDL-c ↑BMC
≥2 MetS components ↓BMC
Increased WC ↑visceral adipose
tissue, fasting insulin and
HOMA-IR ↓total body BMC
Lawlor et al. [5] United Kingdom 2035 adolescents
(15 years)




Reduced HDL and insulin
resistance ↓total body BMD, BMC
Lee et al. [14] South Korea 618 adolescents
(10 to 19 years)
Cross-sectional BMC using DXA HOMA-IR ↓BMC in boys
Nóbrega da Silva et al. [7] Brazil 270 overweight adolescents
(10 to 16 years)
Cross-sectional BMD using DXA MetS (+)↓BMD/kg weight lumbar
spine, left proximal femur, total
and subtotal body
Increased WC ↓BMD (lumbar
spine and total body) in both genders
Hypertriglyceridemia ↓BMD (lumbar
spine and total body) in girls.
BMC bone mineral content, BMD bone mineral density, MetS(+) with metabolic syndrome, WC waist circumference
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Puberty and evaluation of bone mass
The period of puberty is characterized by the occur-
rence of a fundamental process, i.e., the maximum ac-
quisition of BMC [12, 21–24]. Bone tissue is composed
of cells, called osteoblasts and osteoclasts, minerals
(calcium and phosphorus), and an organic matrix con-
sisting of collagen and non-collagen proteins. Osteo-
blasts synthesize and mineralize the protein matrix,
while osteoclasts promote bone resorption, maintaining
the bone tissue in a constant process of remodeling.
During childhood and adolescence, the rate of bone
formation exceeds that of bone resorption, favoring
bone acquisition [22, 25]. Approximately 40 to 45% of
adult bone mass is acquired during adolescence [26]. In
this respect, periods of skeletal growth, especially dur-
ing adolescence, are fundamental for peak bone mass
acquisition and to reduce the risk of developing skeletal
morbidities such as osteopenia/osteoporosis and fragil-
ity fractures in old age [13, 14, 21, 27]. In both genders,
peak bone mass acquisition occurs around seven or
eight months after maximum longitudinal bone growth
(growth spurt) as a result of high concentrations of
hormones [22, 24, 25, 28, 29].
The occurrence of low bone mass in children and ado-
lescents has been identified in recent years and has raised
the interest of the scientific community [4, 30]. On the
one hand, there is growing awareness that bone mineral
mass acquired at the end of growth and its development
are crucial for reducing the risk of osteoporosis in the fu-
ture. On the other hand, osteoporosis is increasingly more
prevalent and also occurs in young patients, since BMD in
these age groups depends on peak bone mass acquired by
the end of the second decade of life [31].
The increase in recent decades in the frequency of
fractures in childhood from 35% to 65% has raised con-
cerns that the current lifestyle is compromising early
bone health [30]. Bone densitometry detects bone mass
losses of less than 5%. The interpretation of DXA results
in the pediatric population is a challenge because of the
changes in bone size and geometry that occur during
growth and child development. Adequate interpretation
of the results should take into consideration skeletal ma-
turity, pubertal development, ethnic background, weight,
and height of the patient [25].
Metabolic syndrome, risk factors and bone mass
The presence of central obesity, defined by increased
waist circumference, and at least two of the following
four criteria are necessary for the diagnosis of MetS:
triglyceride elevation (≥150 mg/dL); reduction in HDL-
cholesterol (<40 mg/dL); arterial hypertension (SBP ≥
130/DBP ≥ 85 mmHg); and fasting hyperglycemia (blood
glucose ≥100 mg/dL), or previously diagnosed type 2
diabetes. [1].
According to Nóbrega et al. [7], the prevalence of MetS
was 14% among 271 adolescents, being 13.29% and 15.93%
for female and male adolescents respectively. In relation to
the components of MetS, there was a higher prevalence in
the increase in waist circumference (67.82%), reduction in
HDLc (32.09%), Hypertension (22.62%), Hypertriglyc-
eridemia (19.78%), and Hyperglycemia (3.37%).
Within the global context of an increasing prevalence of
obesity and other cardiovascular risk factors in children
and adolescents, the role of MetS is particularly import-
ant, however, despite this, it has been little investigated in
the literature. In addition to the health problems already
documented in the scientific literature, previous studies
have provided indicators of a relationship between MetS
and bone mass in the young and adult population, but the
results are still inconsistent [3, 4, 6, 7].
Waist circumference and bone mass
Several mechanisms of action can be proposed for the re-
percussions of MetS components on bone mass (Fig. 1).
Visceral obesity determined by the evaluation of waist
circumference is an important factor that contributes to
the negative association with BMD, suggesting that fat,
particularly visceral fat, is deleterious to bone mass [4, 18,
32, 33]. In addition to its role in the storage and
mobilization of lipids, visceral fat has also been considered
an endocrine organ that releases adipokines and cytokines,
including proinflammatory molecules such as interleukin
6 (IL-6) and tumor necrosis factor alpha (TNF-α) [34].
There is consensus that IL-6 and TNF-α promote bone re-
sorption by stimulating the differentiation of osteoclasts
[35] (Fig. 1). Furthermore, the accumulation of visceral
fat, lipid profile alterations and blood pressure changes,
the main components involved in MetS, are significantly
correlated with low serum levels of osteocalcin in the
adult population, which is considered a sensitive marker
of bone formation [36, 37].
In obese children, circulating osteocalcin levels were
found to be lower than in eutrophic children and were
positively correlated with the presence of insulin resist-
ance and negatively with serum leptin concentration [38].
Recently, Kim et al. [39] investigated the association of
serum total osteocalcin with obesity and MetS in Korean
children and identified significantly lower osteocalcin
levels in overweight and obese children compared to the
mean values obtained for eutrophic children. The authors
observed a negative correlation between osteocalcin and
adiposity. This significant negative correlation between
osteocalcin and body fat percentage was maintained even
when the variables were adjusted for gender and age. The
authors also found significant differences in osteocalcin
and MetS between groups. Participants without MetS
components had significantly higher osteocalcin levels
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than those with one or two risk factors for MetS, in
addition to increased waist circumference.
Regarding other factors with a negative impact on bone
metabolism, elevated leptin concentrations are detected in
obese children and adolescents based on the fact that they
accelerate bone resorption and reduce bone formation.
The consequences are alterations in the bone microstruc-
ture of these individuals and an increased fracture risk
[40, 41]. Two mechanisms of action of leptin on bone
mass have been proposed: one through sympathetic activ-
ity in which leptin binds to hypothalamic receptors,
increasing the expression of RANKL and consequently
bone resorption, and the other through cocaine- and
amphetamine-regulated transcription, which results in the
inhibition of RANKL [42, 43].
Dyslipidemia and bone mass
Knowledge of the mechanisms related to the participation
of HDL-cholesterol in the calcification of vascular lesions
can be applied to the understanding of its effect on skel-
etal formation [44]. A possible explanation of the effect of
HDL-cholesterol is that this lipoprotein inhibits the osteo-
genic activity of vascular cells by inducing inflammatory
cytokines such as IL-1β and IL-6. Oxidation of HDL-
cholesterol renders it pro-osteogenic, suggesting that
HDL-cholesterol regulates the differentiation of osteo-
blasts, the cells involved in the formation of bone tissue
[44] (Fig. 1). Also regarding the detection of hypercholes-
terolemia, Abramowicz et al. [45] observed negative corre-
lations of lumbar spine BMD and total body BMC with
increased total cholesterol in overweight/obese girls, but
not in boys. The authors suggested that the risk of cardio-
vascular events and osteoporosis later in life would be
higher in these girls.
In adults, a previous study highlighted that elevated
levels of triglycerides are negatively correlated with fem-
oral neck BMD in postmenopausal women and are detri-
mental to bone mass [3]. Thus, it appears that high levels
of triglycerides are also harmful to bone in adolescents [7].
A negative correlation with BMD at all sites analyzed has
been observed in adolescent girls aged 10 to 16 years [7].
Bredella et al. [46] focused on bone marrow fat since
this is the site of stem cell differentiation into osteo-
blasts, the cells responsible for bone formation. In that
study, the authors used magnetic resonance spectros-
copy to accurately measure bone marrow fat content in
106 obese subjects ranging in age from 19 to 45 years.
The study revealed high levels of bone marrow fat in
subjects with increased liver and muscle fat content and
these results were independent of body mass index, age
and exercise status. Furthermore, HDL-cholesterol was
associated with a lower risk of heart disease and was
inversely associated with bone marrow fat content. The
authors observed that triglycerides were positively corre-
lated with bone marrow fat, possibly because this type of
fat stimulates osteoclasts, the cells that degrade bone tis-
sue. The authors highlighted the fact that high levels of
bone marrow fat increase the risk of fracture [46].
Arterial hypertension and bone mass
Arterial hypertension can be associated with abnormal cal-
cium homeostasis, resulting in an increase in the urinary
Fig. 1 Metabolic Syndrome and decrease in bone mass with explanations
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excretion of this mineral [44] (Fig. 1). An association
between low BMD and arterial hypertension has been
described in men and in postmenopausal women [47, 48].
However, Pollock et al. [4] found no association between
arterial hypertension and bone mass in overweight adoles-
cents. Pludowski et al. [49] reported the presence of lower
bone mass evaluated based on total body BMC in 94
adolescents (21 girls and 73 boys) with primary hyperten-
sion compared to a control group without hypertension
(n = 562) after adjusting for body weight and lean mass.
Although reduced, BMC was within the physiological
range. The hypothesis of that study was based on the fact
that, in adults, both events (hypertension and osteopor-
osis) result from a reduction in physical activity and poor
eating habits such as diets rich in sodium and low in cal-
cium. Afgahani and Goran [50] suggested hypertension to
be a risk factor for osteopenia observed in 187 overweight
Latino children and adolescents. This risk was more evi-
dent in adolescent boys in late puberty.
Hyperglycemia and bone mass
There is no consensus in the literature regarding the
association between altered glucose levels and BMD
during adolescence. The mechanisms have not yet been
fully unraveled and studies suggest that abnormal glu-
cose levels may negatively affect bone through multiple
pathways, including an increase in the concentrations
of advanced glycated end-products, hypercalcuria associ-
ated with glycosuria, a reduction in insulin-like growth
factor 1, an increase in inflammatory processes and cyto-
kines, and microvascular complications resulting from
diabetes and the consequent reduction in blood flow to
bone [44, 51] (Fig. 1). Within this context, further studies
are needed to explore these associations [44].
Conclusion
The associations between MetS and bone mass develop-
ment in adolescents have not been widely explored and
the results have been poorly enlightening. Prospective
studies are therefore necessary to explore these associa-
tions since the presence of low BMD during adolescence
can significantly compromise peak bone mass acquisition,
with a consequent risk of fractures during this phase of life
and bone fragility later in life.
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